HeartSciences Inc.
HSCS
$3.46
$0.113.28%
NASDAQ
| 01/31/2025 | 10/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 70.26% | -7.59% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 19.47% | -4.37% | |||
| Operating Income | -19.47% | 4.37% | |||
| Income Before Tax | -21.77% | -1.52% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -21.77% | -1.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -21.77% | -1.52% | |||
| EBIT | -19.47% | 4.37% | |||
| EBITDA | -19.91% | 4.41% | |||
| EPS Basic | -13.30% | 13.94% | |||
| Normalized Basic EPS | -13.29% | 13.93% | |||
| EPS Diluted | -13.30% | 13.94% | |||
| Normalized Diluted EPS | -13.29% | 13.93% | |||
| Average Basic Shares Outstanding | 7.49% | 17.96% | |||
| Average Diluted Shares Outstanding | 7.49% | 17.96% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||